Our clinicians can help review your medical history, baseline labs, medication eligibility, insurance pathway, side-effect concerns, and long-term maintenance plan
Semaglutide For Weight Loss Obesity is a global health challenge that affects millions of people, often leading to a host of associated health problems such as diabetes, heart disease, and joint issues
In human oocytes, metabolic tracer studies have revealed increased glucose and pyruvate consumption, likely a compensatory mechanism to offset mitochondrial inefficiency (60)
GLP-1 Drugs and Eating Disorders: A Hidden Risk in the Weight Loss Revolution By Donnisa Edmonds, C2ST Intern, University of Chicago In 2021, the FDA announced that they had approved Wegovy, a GLP-1 receptor agonist, as a treatment for chronic weight management